Cited by 56BRCA gene mutations in cancerGenetic factors in colorectal cancerGenomics and Rare Diseases

Penetrance and Expressivity in Inherited Cancer Predisposing Syndromes

Taeubner, Julia, Wieczorek, Dagmar, Yasin, Layal, Brozou, Triantafyllia, Borkhardt, Arndt, Kuhlen, Michaela·2018·Trends in Cancer

Abstract

Inherited diseases are not always expressed in the same way in every individual that carries the same variant in a disease-causing gene. This phenomenon is known as reduced or incomplete penetrance. Variable and incomplete penetrance may explain why inherited diseases are occasionally transmitted through unaffected parents, but also why clinically healthy individuals can carry potentially pathogenic variants without expressing features of the disease. Here, we will provide an overview of factors that play a fundamental role in the concept of penetrance and expressivity of cancer predisposing genes in children with malignancies. These findings are important to understand the complexity of inherited diseases and cancer development and to improve genetic counselling for the affected families.

Integrity signals

Registry

Crossref · 10.1016/j.trecan.2018.09.002

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The study could not correctly assess the influence of environmental factors and modifier genes on penetrance of APOE mutations.

    “Meanwhile, it also prevents the correct and comprehensive assessment of the influence of environmental factors and modifier genes on the penetrance of APOE mutations9,18, 19, 20, 21”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Taeubner, J., Wieczorek, D., Yasin, L., Brozou, T., Borkhardt, A., & Kuhlen, M.
Affiliations
Heinrich Heine University Düsseldorf (DE)
Corresponding author
Kuhlen, Michaela
Venue
Trends in Cancer
Publisher
Elsevier BV
Published
2018-11
Volume
4
Issue
11
Pages
718-728
ISSN
  • 2405-8025 (ISSN-L)
  • 2405-8033
OpenAlex
W2890744727
Cited by
56
References
4
Citations by year
2026: 13 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 8 · 2021: 13 · 2020: 6 · 2019: 3 · 2018: 1
FWCI
0.79
Type
journal article
Language
en
Open access
closed
Locations
  • Trends in cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
penetrance, expressivity, hereditary cancer, incomplete penetrance, variable expressivity, pathogenic variants, pediatric malignancies, genetic counseling
MeSH terms
Humans, Neoplasms, Risk Factors, Syndrome, Genetic Variation, Penetrance, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review